You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Response-adapted

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lymphoma Trial (Ultra Low Dose 4 Gy Radiation)

Not yet recruiting
  • Lymphoma
  • Ultra Low Dose 4 Gy Radiation
  • (no location specified)
Jun 30, 2023

Hodgkin Lymphoma Trial (Tislelizumab, AVD, Radiotherapy)

Not yet recruiting
  • Hodgkin Lymphoma
  • Tislelizumab, AVD, Radiotherapy
  • (no location specified)
Nov 15, 2022

Multiple Myeloma Trial (Continued treatment adapted to the response)

Completed
  • Multiple Myeloma
  • Continued treatment adapted to the response
  • (no location specified)
Jan 14, 2023

Diffuse Large B Cell Lymphoma (DLBCL) Trial in Toronto (glofitamab)

Not yet recruiting
  • Diffuse Large B Cell Lymphoma (DLBCL)
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Sep 18, 2023

Follicular Lymphoma, Non-Hodgkin's Lymphoma, NHL Trial run by the National Cancer Institute (NCI) (Rituximab, Copanlisib)

Recruiting
  • Follicular Lymphoma
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 25, 2023

Gastroesophageal Adenocarcinoma Trial in Orange (device, combination product, drug)

Not yet recruiting
  • Gastroesophageal Adenocarcinoma
  • ctDNA Blood Test
  • +8 more
  • Orange, California
    Chao Family Comprehensive Cancer Center, University
Feb 8, 2023

Triple Negative Breast Cancer, Breast Cancer Trial in United States (Carboplatin, Docetaxel, Doxorubicin)

Recruiting
  • Triple Negative Breast Cancer
  • Breast Cancer
  • Fairway, Kansas
  • +5 more
Jan 26, 2023

Hemophagocytic Lymphohistiocytosis Trial in United States (Ruxolitinib, Dexamethasone, Etoposide)

Recruiting
  • Hemophagocytic Lymphohistiocytosis
  • Phoenix, Arizona
  • +9 more
Jan 9, 2023

Head Neck Cancer Trial in Beijin (anti-PD-1 or PD-L1 antibody, postoperative radiaotherapy)

Recruiting
  • Head and Neck Cancer
  • anti-PD-1 or PD-L1 antibody
  • postoperative radiaotherapy
  • Beijin, Beijing, China
    National Cancer Center /National Clinical Research Center for Ca
Mar 18, 2023

Nasopharyngeal Cancer Trial in Shanghai (Toripalimab, Induction chemo and concurrent chemoradiation)

Recruiting
  • Nasopharyngeal Cancer
  • Toripalimab
  • Induction chemotherapy and concurrent chemoradiation
  • Shanghai, Shanghai, China
    Fudan Universtiy Shanghai Cancer Centre
Nov 25, 2022

Chronic Lymphocytic Leukemia Trial (Evaluation of response to treatment with response-tailored Ibrutinib in patients with

Not yet recruiting
  • Chronic Lymphocytic Leukemia
  • Evaluation of response to treatment with response-tailored Ibrutinib in patients with chronic lymphocytic leukemia
  • (no location specified)
Dec 27, 2022

Breast Cancer Trial in Shanghai (axillary surgery de-escalation after NAT)

Recruiting
  • Breast Cancer
  • axillary surgery de-escalation after NAT
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center Shanghai, China, 200032
Jun 13, 2023

Renal Cell Cancer Trial (Axitinib, Pembrolizumab)

Withdrawn
  • Renal Cell Cancer
  • (no location specified)
Jul 29, 2022

Multiple Myeloma Trial in Birmingham (DaraVRD)

Recruiting
  • Multiple Myeloma
  • Birmingham, Alabama
    University of Alabama at Birmingham
Oct 20, 2021

Hodgkin Lymphoma Trial in Salt Lake City (Axatilimab, Nivolumab)

Not yet recruiting
  • Hodgkin Lymphoma
  • Salt Lake City, Utah
    Huntsman Cancer Institute at the University of Utah
Feb 1, 2023

Non Small Cell Lung Cancer Metastatic Trial in Morgantown (Radiation, Immuno-Therapeutic Agent)

Active, not recruiting
  • Non Small Cell Lung Cancer Metastatic
  • Radiation
  • Immuno-Therapeutic Agent
  • Morgantown, West Virginia
    WVU Cancer Institute - Mary Babb Randolph Cancer Center
Apr 25, 2022

Advanced Hodgkin Lymphoma Trial in Worldwide (Brentuximab Vedotin, Adriamycin, Vinblastine)

Active, not recruiting
  • Advanced Hodgkin Lymphoma
  • Brentuximab Vedotin
  • +6 more
  • Antwerp, Belgium
  • +18 more
May 4, 2022

Choroideremia Trial in Durham (Vitamin A palmitate)

Not yet recruiting
  • Choroideremia
  • Vitamin A palmitate
  • Durham, North Carolina
    Duke Eye Center
Apr 8, 2022

Chronic Respiratory Disease Trial in Hauteville-Lompnes (Adapted information arm, Neutral information arm)

Recruiting
  • Chronic Respiratory Disease
  • Adapted information arm
  • Neutral information arm
  • Hauteville-Lompnes, France
  • +1 more
Jan 16, 2023

Multiple Myeloma Trial in Tampa (Lenalidomide, Prednisone, Dexamethasone)

Completed
Has Results
  • Multiple Myeloma
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Oct 8, 2021

Hepatoblastoma Trial in Shanghai (Sodium Thiosulfate Injection, Primary surgery resection, mono CDDP-Group A2)

Recruiting
  • Hepatoblastoma
  • Sodium Thiosulfate Injection
  • +10 more
  • Shanghai, Shanghai, China
    Shanghai Children's Medical Center
Jul 23, 2022

Peripheral Arterial Disease Trial in Worldwide (Duplex Ultrasound (DUS), IVUS with Intraarterial pressure measurement (IAP) if

Active, not recruiting
  • Peripheral Arterial Disease
  • Duplex Ultrasound (DUS)
  • IVUS with Intraarterial pressure measurement (IAP) if needed
  • Perth, Western Australia, Australia
  • +14 more
Aug 24, 2022

Lymphoma, Non-Hodgkin's, Adult Trial in Rosario, Caba (Evaluation of first line treatment in patients with stage I and II LBCL)

Recruiting
  • Lymphoma, Non-Hodgkin's, Adult
  • Evaluation of first line treatment in patients with stage I and II LBCL
  • Paraná, Entre Ríos, Argentina
  • +6 more
Dec 29, 2022

Breast Cancer Trial in Worldwide (Perjeta, Herceptin, Docetaxel)

Active, not recruiting
  • Breast Cancer
  • Bruxelles, Belgium
  • +55 more
Jan 18, 2023

Hodgkin Lymphoma Trial in Copenhagen (ABVD + FDG-PET/CT Scan treatment adaptation, BEACOPPesc)

Withdrawn
  • Hodgkin Lymphoma
  • ABVD + FDG-PET/CT Scan treatment adaptation
  • BEACOPPesc
  • Copenhagen, Denmark
    Rigshospitalet
Feb 11, 2021